Associate Director, Medical Affairs (Lymphoma/Leukemia)

Location: United States, California, Santa Monica

Salary: $195,670–$253,220 annually for the Bay Area; other US locations: $177,905–$230,230 annually.

Company

Biopharmaceutical organization developing cancer immunotherapies, including CAR T-cell and T-cell receptor engineered cell therapies.

What you will do

• Support the development and execution of global medical strategy for lymphoma and leukemia across marketed products and pipeline indications.
• Develop and execute Medical Affairs tactics, including advisory boards, publications, training, and medical plans of action.
• Provide direction for cross-functional product and disease strategies throughout the product lifecycle.
• Partner with Clinical Development, HEOR, Market Access, Government Affairs, Marketing, RWE, Scientific Communications, and Publications.
• Capture internal and external insights and translate them into actionable activities for the therapy area.
• Engage external experts, medical societies, regulatory groups, and scientific meeting participants while maintaining a thought leader network.

Requirements

• Bachelor’s degree and 10 years of relevant experience, master’s degree and 8 years, or PhD and 2 years.
• Relevant pharmaceutical industry and Medical Affairs experience, ideally in cell therapy and lymphoma/leukemia.
• M.D., Pharm.D., PhD, or a life sciences, immunology, or oncology qualification preferred.
• Strong written and verbal communication, organizational, judgment, teamwork, and matrix collaboration skills.
• Basic knowledge of budget and account management.
• Ability to travel to domestic and international conferences, approximately 35%.

Culture & Benefits

• Full-time employee position with paid time off.
• Company-sponsored medical, dental, vision, and life insurance plans.
• Potential eligibility for a discretionary annual bonus and stock-based long-term incentives.
• Inclusive work environment focused on employee development, empowerment, and diverse perspectives.